Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor a mediated angiogenesis in liver cancer

Ching Ying Chen, Sheng Ming Wu, Yang Hsiang Lin, Hsiang Cheng Chi, Syuan Ling Lin, Chau Ting Yeh, Wen Yu Chuang, Kwang Huei Lin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background & Aims: Hepatocellular carcinoma (HCC) is among the leading causes of cancer deaths worldwide. Many studies indicate that disruption of cellular thyroid hormone signaling promotes HCC progression. However, the mechanisms underlying the regulation of genes downstream of thyroid hormone actions in HCC have remained elusive. In the current study, we identified NUPR1 (nuclear protein-1), a stress-induced protein that overexpresses in various neoplasia, is upregulated by triiodothyronine/thyroid hormone receptor (T3/TR) signaling and aimed to elucidate its role in angiogenesis in cancer progression. Methods: Quantitative reverse transcription-PCR, luciferase promoter and chromatin immunoprecipitation assays were performed to identify the NUPR1 regulatory mechanism by T3/TR. In vitro and In vivo vascular formations were performed to detect the angiogenic function of NUPR1. Human angiogenesis arrays were performed to identify the downstream angiogenic pathway. The sorafenib resistant ability of TR/NUPR1 was further examined in vitro and in vivo. Clinical relevance of TR, NUPR1 and platelet-derived growth factor A (PDGFA) were investigate in HCC samples using qRT-PCR and western blot. Results: Our experiments disclosed positive regulation of NUPR1 expression by T3/TR through direct binding to the-2066 to-1910 region of the NUPR1 promoter. Elevated NUPR1 and TR expression link to poor survival in clinical HCC specimens. An analysis of clinicopathological parameters showed that expression of NUPR1 is associated with vascular invasion and pathology stage. Functional studies revealed that NUPR1 induced endothelial cell angiogenesis in vitro and in vivo. Using a human angiogenesis array, we identified PDGFA as a target of NUPR1 in the downstream angiogenic pathway. NUPR1 induced transcription of PDGFA through direct binding to the corresponding promoter region, and inhibition of the PDGFA signaling pathway impaired angiogenesis in human umbilical vein endothelial cells (HUVECs). Notably, the angiogenic effects of NUPR1/PDGFA were mediated by the MEK/ERK signaling pathway. TR/NUPR1 expression increased cell viability and resistance to sorafenib treatment. Moreover NUPR1 expression was positively correlated with TRα, TRβ, and PDGFA expression. Conclusions: We propose that the T3/TR/NUPR1/PDGFA/MEK/ERK axis has a vital role in hepatocarcinogenesis and suggest NUPR1 as a potential therapeutic target in HCC.

Original languageEnglish
Pages (from-to)2361-2379
Number of pages19
JournalTheranostics
Volume9
Issue number8
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Platelet-Derived Growth Factor
Liver Neoplasms
Nuclear Proteins
Thyroid Hormones
Hepatocellular Carcinoma
Blood Vessels
Thyroid Hormone Receptors
Neoplasms
Polymerase Chain Reaction
MAP Kinase Signaling System
Chromatin Immunoprecipitation
Mitogen-Activated Protein Kinase Kinases
Human Umbilical Vein Endothelial Cells
Triiodothyronine
Heat-Shock Proteins
platelet-derived growth factor A
Luciferases
Genetic Promoter Regions

Keywords

  • Hepatocellular carcinoma
  • NUPR1
  • PDGFA
  • Sorafenib
  • Thyroid hormone receptor

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor a mediated angiogenesis in liver cancer. / Chen, Ching Ying; Wu, Sheng Ming; Lin, Yang Hsiang; Chi, Hsiang Cheng; Lin, Syuan Ling; Yeh, Chau Ting; Chuang, Wen Yu; Lin, Kwang Huei.

In: Theranostics, Vol. 9, No. 8, 01.01.2019, p. 2361-2379.

Research output: Contribution to journalArticle

Chen, Ching Ying ; Wu, Sheng Ming ; Lin, Yang Hsiang ; Chi, Hsiang Cheng ; Lin, Syuan Ling ; Yeh, Chau Ting ; Chuang, Wen Yu ; Lin, Kwang Huei. / Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor a mediated angiogenesis in liver cancer. In: Theranostics. 2019 ; Vol. 9, No. 8. pp. 2361-2379.
@article{a09276f3e241444c988c60681ce3925b,
title = "Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor a mediated angiogenesis in liver cancer",
abstract = "Background & Aims: Hepatocellular carcinoma (HCC) is among the leading causes of cancer deaths worldwide. Many studies indicate that disruption of cellular thyroid hormone signaling promotes HCC progression. However, the mechanisms underlying the regulation of genes downstream of thyroid hormone actions in HCC have remained elusive. In the current study, we identified NUPR1 (nuclear protein-1), a stress-induced protein that overexpresses in various neoplasia, is upregulated by triiodothyronine/thyroid hormone receptor (T3/TR) signaling and aimed to elucidate its role in angiogenesis in cancer progression. Methods: Quantitative reverse transcription-PCR, luciferase promoter and chromatin immunoprecipitation assays were performed to identify the NUPR1 regulatory mechanism by T3/TR. In vitro and In vivo vascular formations were performed to detect the angiogenic function of NUPR1. Human angiogenesis arrays were performed to identify the downstream angiogenic pathway. The sorafenib resistant ability of TR/NUPR1 was further examined in vitro and in vivo. Clinical relevance of TR, NUPR1 and platelet-derived growth factor A (PDGFA) were investigate in HCC samples using qRT-PCR and western blot. Results: Our experiments disclosed positive regulation of NUPR1 expression by T3/TR through direct binding to the-2066 to-1910 region of the NUPR1 promoter. Elevated NUPR1 and TR expression link to poor survival in clinical HCC specimens. An analysis of clinicopathological parameters showed that expression of NUPR1 is associated with vascular invasion and pathology stage. Functional studies revealed that NUPR1 induced endothelial cell angiogenesis in vitro and in vivo. Using a human angiogenesis array, we identified PDGFA as a target of NUPR1 in the downstream angiogenic pathway. NUPR1 induced transcription of PDGFA through direct binding to the corresponding promoter region, and inhibition of the PDGFA signaling pathway impaired angiogenesis in human umbilical vein endothelial cells (HUVECs). Notably, the angiogenic effects of NUPR1/PDGFA were mediated by the MEK/ERK signaling pathway. TR/NUPR1 expression increased cell viability and resistance to sorafenib treatment. Moreover NUPR1 expression was positively correlated with TRα, TRβ, and PDGFA expression. Conclusions: We propose that the T3/TR/NUPR1/PDGFA/MEK/ERK axis has a vital role in hepatocarcinogenesis and suggest NUPR1 as a potential therapeutic target in HCC.",
keywords = "Hepatocellular carcinoma, NUPR1, PDGFA, Sorafenib, Thyroid hormone receptor",
author = "Chen, {Ching Ying} and Wu, {Sheng Ming} and Lin, {Yang Hsiang} and Chi, {Hsiang Cheng} and Lin, {Syuan Ling} and Yeh, {Chau Ting} and Chuang, {Wen Yu} and Lin, {Kwang Huei}",
year = "2019",
month = "1",
day = "1",
doi = "10.7150/thno.29628",
language = "English",
volume = "9",
pages = "2361--2379",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "8",

}

TY - JOUR

T1 - Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor a mediated angiogenesis in liver cancer

AU - Chen, Ching Ying

AU - Wu, Sheng Ming

AU - Lin, Yang Hsiang

AU - Chi, Hsiang Cheng

AU - Lin, Syuan Ling

AU - Yeh, Chau Ting

AU - Chuang, Wen Yu

AU - Lin, Kwang Huei

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background & Aims: Hepatocellular carcinoma (HCC) is among the leading causes of cancer deaths worldwide. Many studies indicate that disruption of cellular thyroid hormone signaling promotes HCC progression. However, the mechanisms underlying the regulation of genes downstream of thyroid hormone actions in HCC have remained elusive. In the current study, we identified NUPR1 (nuclear protein-1), a stress-induced protein that overexpresses in various neoplasia, is upregulated by triiodothyronine/thyroid hormone receptor (T3/TR) signaling and aimed to elucidate its role in angiogenesis in cancer progression. Methods: Quantitative reverse transcription-PCR, luciferase promoter and chromatin immunoprecipitation assays were performed to identify the NUPR1 regulatory mechanism by T3/TR. In vitro and In vivo vascular formations were performed to detect the angiogenic function of NUPR1. Human angiogenesis arrays were performed to identify the downstream angiogenic pathway. The sorafenib resistant ability of TR/NUPR1 was further examined in vitro and in vivo. Clinical relevance of TR, NUPR1 and platelet-derived growth factor A (PDGFA) were investigate in HCC samples using qRT-PCR and western blot. Results: Our experiments disclosed positive regulation of NUPR1 expression by T3/TR through direct binding to the-2066 to-1910 region of the NUPR1 promoter. Elevated NUPR1 and TR expression link to poor survival in clinical HCC specimens. An analysis of clinicopathological parameters showed that expression of NUPR1 is associated with vascular invasion and pathology stage. Functional studies revealed that NUPR1 induced endothelial cell angiogenesis in vitro and in vivo. Using a human angiogenesis array, we identified PDGFA as a target of NUPR1 in the downstream angiogenic pathway. NUPR1 induced transcription of PDGFA through direct binding to the corresponding promoter region, and inhibition of the PDGFA signaling pathway impaired angiogenesis in human umbilical vein endothelial cells (HUVECs). Notably, the angiogenic effects of NUPR1/PDGFA were mediated by the MEK/ERK signaling pathway. TR/NUPR1 expression increased cell viability and resistance to sorafenib treatment. Moreover NUPR1 expression was positively correlated with TRα, TRβ, and PDGFA expression. Conclusions: We propose that the T3/TR/NUPR1/PDGFA/MEK/ERK axis has a vital role in hepatocarcinogenesis and suggest NUPR1 as a potential therapeutic target in HCC.

AB - Background & Aims: Hepatocellular carcinoma (HCC) is among the leading causes of cancer deaths worldwide. Many studies indicate that disruption of cellular thyroid hormone signaling promotes HCC progression. However, the mechanisms underlying the regulation of genes downstream of thyroid hormone actions in HCC have remained elusive. In the current study, we identified NUPR1 (nuclear protein-1), a stress-induced protein that overexpresses in various neoplasia, is upregulated by triiodothyronine/thyroid hormone receptor (T3/TR) signaling and aimed to elucidate its role in angiogenesis in cancer progression. Methods: Quantitative reverse transcription-PCR, luciferase promoter and chromatin immunoprecipitation assays were performed to identify the NUPR1 regulatory mechanism by T3/TR. In vitro and In vivo vascular formations were performed to detect the angiogenic function of NUPR1. Human angiogenesis arrays were performed to identify the downstream angiogenic pathway. The sorafenib resistant ability of TR/NUPR1 was further examined in vitro and in vivo. Clinical relevance of TR, NUPR1 and platelet-derived growth factor A (PDGFA) were investigate in HCC samples using qRT-PCR and western blot. Results: Our experiments disclosed positive regulation of NUPR1 expression by T3/TR through direct binding to the-2066 to-1910 region of the NUPR1 promoter. Elevated NUPR1 and TR expression link to poor survival in clinical HCC specimens. An analysis of clinicopathological parameters showed that expression of NUPR1 is associated with vascular invasion and pathology stage. Functional studies revealed that NUPR1 induced endothelial cell angiogenesis in vitro and in vivo. Using a human angiogenesis array, we identified PDGFA as a target of NUPR1 in the downstream angiogenic pathway. NUPR1 induced transcription of PDGFA through direct binding to the corresponding promoter region, and inhibition of the PDGFA signaling pathway impaired angiogenesis in human umbilical vein endothelial cells (HUVECs). Notably, the angiogenic effects of NUPR1/PDGFA were mediated by the MEK/ERK signaling pathway. TR/NUPR1 expression increased cell viability and resistance to sorafenib treatment. Moreover NUPR1 expression was positively correlated with TRα, TRβ, and PDGFA expression. Conclusions: We propose that the T3/TR/NUPR1/PDGFA/MEK/ERK axis has a vital role in hepatocarcinogenesis and suggest NUPR1 as a potential therapeutic target in HCC.

KW - Hepatocellular carcinoma

KW - NUPR1

KW - PDGFA

KW - Sorafenib

KW - Thyroid hormone receptor

UR - http://www.scopus.com/inward/record.url?scp=85066125561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066125561&partnerID=8YFLogxK

U2 - 10.7150/thno.29628

DO - 10.7150/thno.29628

M3 - Article

AN - SCOPUS:85066125561

VL - 9

SP - 2361

EP - 2379

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 8

ER -